Summary & Overview
HCPCS Level II M1328: Acute Vitreous Hemorrhage Evaluation
HCPCS Level II code M1328 designates care for patients diagnosed with acute vitreous hemorrhage, a sudden bleed into the vitreous cavity that can cause rapid visual decline and often prompts urgent ophthalmic evaluation. Nationally, coding clarity for acute ocular emergencies influences access to timely diagnostic and therapeutic services and supports consistent claims processing for emergency eye care. Key payers included in this overview are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an orientation to the code’s clinical context, typical sites of service, and the types of documentation and billing scenarios in which M1328 is used. The publication also outlines common benchmarking topics and policy considerations relevant to payers and providers, including service line placement within ophthalmology and emergency care workflows. Where available, the report summarizes typical payer handling, reimbursement themes, and coding caveats that affect national claim adjudication for acute vitreous hemorrhage. Data not available in the input will be noted as such in relevant sections.
Billing Code Overview
HCPCS Level II code M1328 identifies patients with a diagnosis of acute vitreous hemorrhage. This code denotes services related to the evaluation and management of a sudden-onset intraocular hemorrhage within the vitreous body of the eye.
Service Type: Ophthalmic emergency/urgent evaluation and management
Typical Site of Service: Hospital emergency department, ophthalmology clinic, or ambulatory surgical center
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 68-year-old patient presents to a retinal specialist with sudden onset vision loss and complaints of floaters and a dark curtain in the visual field. Examination with slit lamp and dilated fundus exam suggests an acute vitreous hemorrhage obscuring fundus details. B-scan ocular ultrasonography confirms vitreous blood with no clear retinal detachment. The patient is counseled about observation versus surgical intervention. Initial management often includes outpatient evaluation with activity modification and head positioning while ordering baseline labs and anticoagulation review. If hemorrhage fails to clear or if there is associated tractional or rhegmatogenous retinal detachment, pars plana vitrectomy is scheduled in an operating room under monitored anesthesia care or general anesthesia. Typical sites of service include ambulatory surgical centers and hospital operating rooms. Perioperative workflow includes preoperative evaluation, anesthesia documentation, intraoperative vitrectomy procedure notes, and postoperative follow-up visits documenting visual acuity, intraocular pressure, and retinal status.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when work required is substantially greater than typical for the procedure due to complexity (document rationale). |
23 |